From: Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
Patients no.
Therapy response grade
0–25% (class 1)
38
25–50% (class 2)
29
50–75% (class 3)
35
75–100% (class 4)
48
Drug overuse
Yes
75
No
51
Not assigned
24